Showing Form 4 filings for ADPT
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Adaptive Biotechnologies Corp
Price
$32.00
Shares
1,875
Ownership
387,475
Value/Share
Bobulsky Susan
Chief Commercial Officer, MRD
Unknown
Industry
ADPT
$30.00
6,444
389,350
$27.00
1,195
395,794
$26.00
9,615
78,639
Owen Katey Einterz
Dir
$25.00
3,000
396,989
$24.00
1,299
399,989
$23.00
5,000
401,288
$22.01
386,240
1,019,658
Robins Harlan S
Chief Scientific Officer
$22.00
487
406,288
$20.50
406,775
$17.41
106,160
1,405,898
$19.00
411,775
$18.00
11,000
416,775
$13.04
3,115
256,725
Piskel Kyle
CFO
$14.85
10,000
1,512,058
$14.65
120,595
2,180,518
Robins Chad M
CEO, COB
$14.08
30,593
293,874
Lo Francis
Chief People Officer
$13.17
41,338
427,775
63,103
272,751
Benzeno Sharon
Chief Commercial Ofc Imm Med
18,672
259,840
470,266
1,522,058
470,167
2,301,113
$13.91
15,394
15,625
Griffin Michelle Renee
$15.09
38,074
324,467
$16.19
24,233
1,155,291
$15.85
524,998
1,934,247
$18.44
124,998
2,459,245
$18.68
42,788
1,179,524
$16.44
1,222,312
$15.59
2,584,243
$16.00
22,968
46,722
Hershberg Robert
$18.07
37,212
1,232,312
$19.10
160,734
2,709,241
$14.05
238
269,343
$14.73
89,265
2,869,975
$14.82
1,269,524
$8.89
1,929
269,581
$7.19
36,291
$7.59
53,000
69,690
$6.98
10,320
269,010
59,505
588,249
Rubinstein Julie
Pres, COO
$6.99
96,656
1,279,524
$7.29
219,569
2,959,249
$4.98
248
154,330